Aviko Radiopharmaceuticals

Aviko Radiopharmaceuticals is a privately-held biotechnology company developing pharmaceuticals to unlock the potential of Boron Neutron Capture Therapy (BNCT) for the treatment of various cancers. Aviko's innovative compounds aim to enhance the efficacy of BNCT by precisely targeting and delivering boron to cancer cells. Together with its partners, Aviko is advancing BNCT as a safe, effective, and convenient treatment option for patients.